Go Pro

Richard Scott Blackley Sells 28,869 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Oscar Health CFO Richard Blackley sold 28,869 shares at an average price of $31.45, generating $907,930. The transaction was conducted under a Rule 10b5-1 plan to cover tax obligations from vested equity awards, reducing his holdings by 2.69%.
  • Oscar Health reported strong quarterly results, with EPS of $1.10 versus the $0.40 consensus and revenue of $4.88 billion, up 70.4% year over year.
  • OSCR recently traded at $32.90, near its 12-month high of $33.55, while analysts maintained a consensus “Hold” rating and an average price target of $26.22.
  • Five stocks we like better than Oscar Health.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CFO Richard Blackley sold 28,869 shares of the company's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $907,930.05. Following the transaction, the chief financial officer owned 1,046,108 shares in the company, valued at $32,900,096.60. This represents a 2.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Richard Scott Blackley also recently made the following trade(s):

  • On Tuesday, August 18th, Richard Blackley sold 18,750 shares of Oscar Health stock. The stock was sold at an average price of $31.74, for a total transaction of $595,125.00.

Oscar Health Stock Performance

OSCR stock traded up $0.65 on Tuesday, hitting $32.90. The company had a trading volume of 4,754,751 shares, compared to its average volume of 7,062,275. The stock has a market cap of $10.15 billion, a price-to-earnings ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock's 50-day simple moving average is $30.49 and its 200 day simple moving average is $22.87. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.55.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion for the quarter, compared to analysts' expectations of $4.73 billion. During the same period in the prior year, the firm earned ($0.89) EPS. The company's revenue was up 70.4% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OSCR has been the subject of a number of recent research reports. Weiss Ratings upgraded Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Wall Street Zen upgraded shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a research note on Sunday, June 14th. UBS Group raised their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Piper Sandler restated an "overweight" rating and set a $36.00 target price on shares of Oscar Health in a research report on Tuesday, July 28th. Finally, Robert W. Baird set a $27.00 target price on shares of Oscar Health in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have assigned a Hold rating to the company's stock. According to MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $26.22.

Get Our Latest Analysis on OSCR

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. grew its stake in shares of Oscar Health by 11.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company's stock valued at $132,461,000 after acquiring an additional 910,320 shares during the period. California State Teachers Retirement System raised its stake in Oscar Health by 3,214.2% during the 2nd quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company's stock worth $222,543,000 after acquiring an additional 7,567,600 shares during the period. Morgan Stanley lifted its holdings in Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company's stock valued at $97,918,000 after purchasing an additional 2,043,758 shares in the last quarter. Thrive Capital Management LLC boosted its position in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, BIT Capital GmbH boosted its position in shares of Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Recommended Stories

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines